SPONSOR
Nanjing University School of Medicine
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Lupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R InducedIgG4-Related DiseasesSystemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
NCT06285279 Phase 1
Recruiting
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
Lupus Nephritis
NCT07340463 Phase 2
Recruiting
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Systemic Lupus Erythematosus (SLE)